CLINICAL_TRIALS
trial_result
· 2020-02-21
Clinical Trial Update: Efficacy Study Of Tofacitinib In Pediatric JIA Population [Phase 3]
Summary
Phase 3 trial updating efficacy of tofacitinib in pediatric juvenile idiopathic arthritis has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Juvenile Idiopathic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2020-02-21